Zen Technologies Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/9nu4sesr6ons5m3r6tcwx9z5.pdf

Key Takeaways


The Anti-Drone Opportunity

Ashok Atluri: "if Shahed comes to our border, our responsibility and promise to Shahed is that we will make it Shaheed."

Product Launches & Technology Pipeline

Ashok Atluri: "This may be the largest product in our portfolio two years from now, the biggest product in our portfolio, the interceptor drone... if we are able to crack it, this will be absolute, there is nobody in the world will be able to achieve what we have achieved"

Order Book & Revenue Visibility


Margins & Financial Health

Ashok Atluri: "I do not see any threat to our margin prediction of 25% PAT and 35% EBITDA margins. I think we are very comfortable with the 35% target and I think for this next couple of years that margin profile should continue."

The Indigenous Capability Argument

Ashok Atluri: "We are saying that privately self-funded independent R&D companies, innovation and R&D companies, should actually be treated much, much better than people who are just co-developing with DRDO and that."

Subsidiaries, AI & Organizational Capacity

Ashok Atluri: "Zen comes in there and he says, listen, let us stop all the 15 projects we are doing. The 16th one looks interesting. Let us put in all our resources and create world-class technology there."

Guidance & Commitments

CommitmentSpecificsTimeline
Cumulative turnover₹4,000 crores across FY27 and FY28 combinedFY27–FY28
Order inflow visibilityGood news expected in Q1 to give comfort on current year; orders not later than Q2Q1–Q2 FY27
Operational EBITDA margin35% target, comfortable with continuationNext couple of years
PAT margin25% targetNext couple of years
HyperStrike production startProduction begins; capacity 5,000 per shift per month, scalable to 15,000FY27
Vrishabh UGV commercial launchCommercial launchFY27
Weapon system launchesWeapon systems (12.7mm, 20mm, 30mm) launched during the year; majority launched next yearFY27–FY28
30mm ammunition supplyManufacturing and supplying beginsNext year (FY28)
Subsidiary revenue (UTS + ARI)~₹365 Cr combinedFY27
ARI standalone revenue~₹300 CrFY27
UTS standalone revenue₹150–200 CrFY27
Working capital cycleNormalize to 140–150 days; slight increase if major orders executedOngoing
R&D spendHigher investments, structurally elevated cost baseOngoing

Key Metrics

MetricQ4 FY26
Consolidated revenue₹178.1 cr, broadly in line with ₹177.8 cr in Q3 FY26 and lower by 45.2% YoY
Operational EBITDA₹51 cr, margin of 28.6%, lower by ~900 bps QoQ and 1390 bps YoY
Profit after tax₹47.2 cr, PAT margin of 26.5%
FY26 consolidated revenue₹687.7 cr, lower by 29.4% YoY
FY26 operational EBITDA₹247.2 cr, margin of 35.95%, lower by ~240 bps YoY
FY26 profit after tax₹217.9 cr, PAT margin of 31.7%
Consolidated order book₹1,336 cr as of March 31, 2026
Order book executable in FY27~₹1,000 cr, with most deliveries in Q2 and Q3 FY27; balance ₹326 cr is AMC revenue
Cumulative revenue guidance FY27–FY28₹4,000 cr, management comfortable with this projection
Days sales outstanding~119 days, improved 42 days from 161 days at end of Q3 FY26
Working capital days196 days, compared to 194 days at end of Q3 FY26; guided to 140–150 days longer term
Cash and bank balances₹1,308 cr as of March 31, 2026; group remains debt-free
ARI subsidiary revenue contribution~₹131 cr in FY26, PAT margin of 30.3%
UTS subsidiary PAT margin26.5% for FY26
Subsidiary revenue guidance FY27~₹365 cr combined for UTS and ARI
Hard Kill anti-drone orders received~₹40 cr worth to date
Bidding pipeline~₹1,500 cr in competitive tenders, with single-vendor tenders adding another couple of thousand crores